EQT buys Evidensia from Valedo

The acquisition will see EQT take over Valedo's majority stake through its EQT VI fund, while Stiftelsen Svensk Djursjukvård and Evidensia's management will remain as minority owners in the company.

Valedo's exit comes two years after its first investment in the company in 2012, the same year Evidensia was founded, through the GP's Valedo Partners Fund II.

The company's new owner plans on generating further growth through bolt-ons and increasing market share. EQT's plans are in line with Evidensia's history, which has seen it complete more than 40 acquisitions.

Previous funding
Valedo took a majority stake in Evidensia through an early-stage investment in February 2012, for an undisclosed amount.

Company
Strömsholm-based Valedo was formed as a consolidation of Swedish animal hospitals in 2012, with the history of its portfolio clinics reaching back as far as 1954.

When the company was first acquired, it had five animal hospitals and 10 clinics. Following an acquisition spree under the wing of Valedo, the group now has around 90 clinics and hospitals across Denmark, Sweden, Norway and Finland.

Evidensia employs approximately 1,500 staff, of which 500 are veterinarians, and treats more than 700,000 animals annually, which is estimated to result in sales of nearly SEK 1.4bn in 2014.

People
Anders Thunberg is the CEO of Evidensia.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Nordics
• Buyouts
• Exits
• Consumer
• Secondary buyout
• Sweden
• EQT